Celltrion Targets 33% Shareholder Payout Ratio, Adds 100 Billion Won Share Buyback

| Input:

Biopharmaceutical giant commits to returning one-third of consolidated net profit through dividends and share cancellations, canceling all newly repurchased stock

A view of Celltrion's Plant 1. Photo=Celltrion
A view of Celltrion's Plant 1. Photo=Celltrion

Celltrion announced on Aug. 31 that it will return approximately one-third of its annual consolidated net profit to shareholders moving forward through a combination of cash dividends, share buybacks, and stock cancellations. As part of this commitment, the company’s board approved an additional treasury-share buyback worth approximately 100 billion won ($75 million), with all newly acquired shares slated for immediate cancellation.

In a regulatory filing, Celltrion disclosed a mid- to long-term shareholder return target equal to 33.3% of consolidated net profit.

The shareholder payout ratio will be calculated by combining cash dividends and the market value of canceled treasury shares, divided by consolidated net profit. However, to ensure newly returned value to investors, only treasury shares purchased from 2026 onward and subsequently retired will count toward the payout target. Cancellations of legacy treasury shares acquired prior to 2026 will be excluded from the calculation.

100 Billion Won Repurchase to Be Fully Canceled

Under the new buyback plan, Celltrion will acquire 524,384 common shares on the open market via NH Investment & Securities on the Korea Exchange from Sept. 1 through Nov. 30. The 100 billion won value was calculated based on the closing price of 190,700 won on Aug. 28, the final trading day prior to the board resolution. The actual outlay may fluctuate depending on share price movements during the acquisition window.

The company stated that the buyback is intended to stabilize its share price and enhance long-term shareholder value. All 524,384 repurchased shares will be retired upon completion of the buyback.

With this decision, the total value of treasury-share repurchases approved by Celltrion this year rises to approximately 300 billion won. Celltrion currently holds 3,983,455 common shares in treasury stock, comprising 586,927 shares acquired within distributable profit limits and 3,396,528 shares acquired through other corporate actions.

Predictable Framework Tying Returns to Net Profit

Celltrion has pursued aggressive capital reduction strategies throughout the year. In April, the company retired 9.11 million legacy treasury shares—worth approximately 1.7154 trillion won and representing about 4% of total issued stock. In June, it canceled an additional 488,977 shares acquired earlier in the year, worth roughly 100 billion won.

While April's large-scale cancellation involved previously held stock and thus falls outside the new 33.3% payout formula, all cancellations of shares purchased from 2026 onward will directly count toward the target.

By explicitly linking dividends and share retirements to net earnings, Celltrion aims to establish a transparent and predictable benchmark, enabling investors to anticipate shareholder returns regardless of annual market volatility.

A view of Celltrion Plant 2 Photo=Celltrion
A view of Celltrion Plant 2 Photo=Celltrion

In 2025, Celltrion paid a cash dividend of 750 won per share, totaling approximately 164 billion won—representing a payout ratio of 15.9% based on consolidated net profit. Applying the new 33.3% benchmark to Celltrion’s 2025 consolidated net profit of 1.0315 trillion won yields a theoretical baseline of approximately 340 billion won in total shareholder returns, though actual future distributions will depend on each fiscal year's net income.

In 2025, Celltrion posted consolidated revenue of 4.1625 trillion won and operating profit of 1.1685 trillion won.

×